Victory Capital Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Victory Capital Management's GOSS Position: Q2 2026 in Review
Victory Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 107,141 shares — an estimated $35.2K sold.
Victory Capital Management first reported a position in GOSS in Q1 2019 and held it in 20 quarters. The position peaked at $22M in Q3 2020. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Victory Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
- Victory Capital Management sold 107,141 Gossamer Bio shares in Q2 2026, an estimated $35.2K.
- Victory Capital Management first reported a position in Gossamer Bio in Q1 2019 and held it in 20 quarters.
- Victory Capital Management's Gossamer Bio position peaked at $22M in Q3 2020.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.